CTRI/2020/06/025861招募中3 期
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level, multi centric, non-randomized, comparative, interventional community based study
Department of Ayush Uttarakhand0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female > 18 and < 75 years of age (inclusive).
- •2. The normal healthy individuals.
- •3. High risk individuals.
- •4. Immunosuppressant peoples and subjects with mild to moderate co-morbidities.
- •5. Non-symptomatic subjects under Institutional and Home Quarantine.
- •6. Symptomatic subjects under Institutional Quarantine. (Optional, subject to approval from concerned officials and departments)
- •7. Confirmed COVID-19 cases under isolation and treatment (Optional, subject to approval from concerned officials and departments)
- •8. Signed ICF
排除标准
- •1. Subjects < 18 and > 75 years of age
- •2. Uncontrolled systemic illness.
- •3. Hypersensitivity to any component of Investigational Drug.
- •4. Recent history of drug or alcohol abuse.
- •5. Pregnant female.
- •6. Pre-existing GI symptoms like nausea and vomiting.
- •7. Patients not willing to sign ICF.
- •8. Individuals with severe co-morbidities.
研究者
相似试验
已完成
2 期
Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myelomaplasma cell myelomaJPRN-UMIN000009927Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University33
已完成
Unknown
Verification on the immunomodulatory effects of continuous consumption of dairy productsHealthy adultJPRN-UMIN000053187Meiji Co., Ltd140
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16
已完成
不适用
ipid emulsion (drug) in Acute on Chronic Liver Failure (Liver Disease).CTRI/2018/04/012995Institute of liver and Biliary Sciences90
尚未招募
Unknown
EFFECT Trial: Evaluating Fermentable Fibre as a Long COVID TherapyACTRN12624000356561Monash University40